br00t4c, STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug 'rebate credit'
https://www.statnews.com/2024/03/18/humira-pbms-cvs-caremark-rebate-credits/?utm_campaign=rss
br00t4c, STAT+: As Humira biosimilars take over the market, CVS has created a new ploy: the drug 'rebate credit'
https://www.statnews.com/2024/03/18/humira-pbms-cvs-caremark-rebate-credits/?utm_campaign=rss
Add comment